Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

BACKGROUND: Polypharmacy, often defined as the concomitant use of ≥ 5 medications, has been identified as a significant global public health threat. Aging and multimorbidity are key drivers of polypharmacy and have been linked to a broad range of adverse health outcomes and mortality. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Okpechi, Ikechi G., Tinwala, Mohammed M., Muneer, Shezel, Zaidi, Deenaz, Ye, Feng, Hamonic, Laura N., Khan, Maryam, Sultana, Naima, Brimble, Scott, Grill, Allan, Klarenbach, Scott, Lindeman, Cliff, Molnar, Amber, Nitsch, Dorothea, Ronksley, Paul, Shojai, Soroush, Soos, Boglarka, Tangri, Navdeep, Thompson, Stephanie, Tuot, Delphine, Drummond, Neil, Mangin, Dee, Bello, Aminu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256607/
https://www.ncbi.nlm.nih.gov/pubmed/34218816
http://dx.doi.org/10.1186/s13643-021-01752-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256607/
https://www.ncbi.nlm.nih.gov/pubmed/34218816
http://dx.doi.org/10.1186/s13643-021-01752-z

Ejemplares similares